Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
Coll freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
Coll freshman Avg
|
New words:
affirmative, aseptic, BAM, bile, bowel, bridge, Connecticut, Digestive, fecal, filer, float, idiopathic, irritable, line, malabsorption, Mangini, marker, Nolan, onward, orderly, shelf, Siobhan, syndrome, unsold, Utah
Removed:
analyzed, aptamer, atherosclerotic, attestation, avacincaptad, biomarker, carcinogenicity, cholesterol, concomitant, determination, division, draft, elevating, Endocrinology, endorsed, evolution, federally, feedback, hepatocellular, Hepatology, HFpEF, histopathologic, identity, insured, Intercept, Iveric, lesion, lipoprotein, metabolism, NDA, Nutrition, obeticholic, observation, ortholog, path, pegcetacoplan, pegol, PEGylated, plaque, proliferation, proliferative, prolonged, quarantine, reference, requested, rodent, sequence, statin, thereof, untreated, updated, variant, withdrew
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view